Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 12, Pages 4449
Publisher
MDPI AG
Online
2020-06-23
DOI
10.3390/ijms21124449
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of Advanced Prostate Cancer
- (2019) Min Yuen Teo et al. Annual Review of Medicine
- Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer
- (2019) Shangze Li et al. CANCER RESEARCH
- Activator of G protein signaling 3 modulates prostate tumor development and progression
- (2019) Timothy O Adekoya et al. CARCINOGENESIS
- TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis
- (2019) Yang Hao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Interleukin-7 Contributes to the Invasiveness of Prostate Cancer Cells by Promoting Epithelial–Mesenchymal Transition
- (2019) Min A. Seol et al. Scientific Reports
- CXCL1-LCN2 paracrine axis promotes progression of prostate cancer via the Src activation and epithelial-mesenchymal transition
- (2019) Yongning Lu et al. Cell Communication and Signaling
- IL8 Expression Is Associated with Prostate Cancer Aggressiveness and Androgen Receptor Loss in Primary and Metastatic Prostate Cancer
- (2019) Janielle P. Maynard et al. MOLECULAR CANCER RESEARCH
- Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer
- (2019) Yanjing Li et al. Science Translational Medicine
- CXCL12γ Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine Phenotypes
- (2018) Younghun Jung et al. CANCER RESEARCH
- Enzalutamide and CXCR7 inhibitor combination treatment suppresses cell growth and angiogenic signaling in castration-resistant prostate cancer models
- (2018) Yong Luo et al. INTERNATIONAL JOURNAL OF CANCER
- CX3CL1/fractalkine enhances prostate cancer spinal metastasis by activating the Src/FAK pathway
- (2018) Peng Liu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- TGFβ-induced epithelial-to-mesenchymal transition in prostate cancer cells is mediated via TRPM7 expression
- (2018) Yuyang Sun et al. MOLECULAR CARCINOGENESIS
- Translational models of prostate cancer bone metastasis
- (2018) Richard B. Berish et al. Nature Reviews Urology
- Metastatic Prostate Cancer
- (2018) Oliver Sartor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR− PCa cells
- (2018) Shayna E. Thomas-Jardin et al. PROSTATE
- Genetics and biology of prostate cancer
- (2018) Guocan Wang et al. GENES & DEVELOPMENT
- Identification of the tumour transition states occurring during EMT
- (2018) Ievgenia Pastushenko et al. NATURE
- A molecular portrait of epithelial–mesenchymal plasticity in prostate cancer associated with clinical outcome
- (2018) Nataly Stylianou et al. ONCOGENE
- Epithelial-Mesenchymal Transition and Metastasis under the Control of Transforming Growth Factor β
- (2018) Yutaro Tsubakihara et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinical significance of epithelial-mesenchymal transition markers in prostate cancer
- (2017) Sandy Figiel et al. HUMAN PATHOLOGY
- The Diagnosis and Treatment of Prostate Cancer
- (2017) Mark S. Litwin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- IL-8 promotes proliferation and inhibition of apoptosis via STAT3/AKT/NF-κB pathway in prostate cancer
- (2017) Yidi Guo et al. Molecular Medicine Reports
- RANKL/RANK/OPG cytokine receptor system: mRNA expression pattern in BPH, primary and metastatic prostate cancer disease
- (2017) Frank Christoph et al. WORLD JOURNAL OF UROLOGY
- The RANK/RANKL/OPG system in tumorigenesis and metastasis of cancer stem cell: potential targets for anticancer therapy
- (2017) Mekonnen Sisay et al. OncoTargets and Therapy
- Transforming growth factor β as regulator of cancer stemness and metastasis
- (2016) Claudia Bellomo et al. BRITISH JOURNAL OF CANCER
- Cancer Tills the Premetastatic Field: Mechanistic Basis and Clinical Implications
- (2016) A. R. Chin et al. CLINICAL CANCER RESEARCH
- IL-7/IL-7 receptor axis stimulates prostate cancer cell invasion and migration via AKT/NF-κB pathway
- (2016) Hu Qu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Fractalkine/CX3CL1 induced intercellular adhesion molecule-1-dependent tumor metastasis through the CX3CR1/PI3K/Akt/NF-κB pathway in human osteosarcoma
- (2016) Ju-Fang Liu et al. Oncotarget
- Stability of the hybrid epithelial/mesenchymal phenotype
- (2016) Mohit Kumar Jolly et al. Oncotarget
- CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and αvβ3 integrin clustering
- (2016) Rajesh Singh et al. Oncotarget
- Targeting the CCL2-CCR2 signaling axis in cancer metastasis
- (2016) Su Yin Lim et al. Oncotarget
- The Prognostic Significance of CXCL16 and Its Receptor C-X-C Chemokine Receptor 6 in Prostate Cancer
- (2015) Elin Richardsen et al. AMERICAN JOURNAL OF PATHOLOGY
- Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer
- (2015) Aimalie L. Hardaway et al. CLINICAL & EXPERIMENTAL METASTASIS
- Role of Epithelial Mesenchymal Transition in Prostate Tumorigenesis
- (2015) Mohammad Khan et al. CURRENT PHARMACEUTICAL DESIGN
- Regulation of vascular endothelial growth factor in prostate cancer
- (2015) S. de Brot et al. ENDOCRINE-RELATED CANCER
- Bone metastasis and the metastatic niche
- (2015) Guangwen Ren et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- TGF-β and EGF induced HLA-I downregulation is associated with epithelial-mesenchymal transition (EMT) through upregulation of snail in prostate cancer cells
- (2015) Xiao-Hui Chen et al. MOLECULAR IMMUNOLOGY
- CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells
- (2015) JIEBING TANG et al. ONCOLOGY REPORTS
- Epithelial–Mesenchymal Plasticity: A Central Regulator of Cancer Progression
- (2015) Xin Ye et al. TRENDS IN CELL BIOLOGY
- STAT3 regulated ARF expression suppresses prostate cancer metastasis
- (2015) Jan Pencik et al. Nature Communications
- Cancer metastases: challenges and opportunities
- (2015) Xiangming Guan Acta Pharmaceutica Sinica B
- The Chemokine CCL2 Increases Prostate Tumor Growth and Bone Metastasis through Macrophage and Osteoclast Recruitment
- (2015) Kosuke Mizutani et al. NEOPLASIA
- Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
- (2014) Jason W. Griffith et al. Annual Review of Immunology
- ALCAM/CD166 Is a TGF- -Responsive Marker and Functional Regulator of Prostate Cancer Metastasis to Bone
- (2014) A. G. Hansen et al. CANCER RESEARCH
- RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization
- (2014) Gina Chia-Yi Chu et al. ENDOCRINE-RELATED CANCER
- Role of Fractalkine/CX3CL1 and Its Receptor in the Pathogenesis of Inflammatory and Malignant Diseases with Emphasis on B Cell Malignancies
- (2014) Elisa Ferretti et al. MEDIATORS OF INFLAMMATION
- Annexin 2–CXCL12 Interactions Regulate Metastatic Cell Targeting and Growth in the Bone Marrow
- (2014) Younghun Jung et al. MOLECULAR CANCER RESEARCH
- Pharmacologic Suppression of JAK1/2 by JAK1/2 Inhibitor AZD1480 Potently Inhibits IL-6-Induced Experimental Prostate Cancer Metastases Formation
- (2014) L. Gu et al. MOLECULAR CANCER THERAPEUTICS
- Prostate Cancer and Bone: The Elective Affinities
- (2014) Nadia Rucci et al. Biomed Research International
- Chemokines in Cancer
- (2014) M. T. Chow et al. Cancer Immunology Research
- The Many Faces of Neuroendocrine Differentiation in Prostate Cancer Progression
- (2014) Stéphane Terry et al. Frontiers in Oncology
- CCL2 increases αvβ3 integrin expression and subsequently promotes prostate cancer migration
- (2013) Tien-Huang Lin et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Inflammation and prostate cancer: the role of interleukin 6 (IL-6)
- (2013) Daniel P. Nguyen et al. BJU INTERNATIONAL
- Interleukin-1 Promotes Skeletal Colonization and Progression of Metastatic Prostate Cancer Cells with Neuroendocrine Features
- (2013) Q. Liu et al. CANCER RESEARCH
- Understanding and Targeting Osteoclastic Activity in Prostate Cancer Bone Metastases
- (2013) J.L. Sottnik et al. CURRENT MOLECULAR MEDICINE
- Stabilization of Snail through AKT/GSK-3β signaling pathway is required for TNF-α-induced epithelial–mesenchymal transition in prostate cancer PC3 cells
- (2013) Hao Wang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Regulation of Crosstalk between Epithelial to Mesenchymal Transition Molecules and MMP-9 Mediates the Antimetastatic Activity of Anethole in DU145 Prostate Cancer Cells
- (2013) ByungChul Ha et al. JOURNAL OF NATURAL PRODUCTS
- Endothelial Cells Enhance Prostate Cancer Metastasis via IL-6->Androgen Receptor->TGF- ->MMP-9 Signals
- (2013) X. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
- (2013) T Karantanos et al. ONCOGENE
- Chemokine (C-X-C motif) ligand 1 (CXCL1) protein expression is increased in high-grade prostate cancer
- (2013) Makito Miyake et al. PATHOLOGY RESEARCH AND PRACTICE
- RANKL/RANK/MMP-1 Molecular Triad Contributes to the Metastatic Phenotype of Breast and Prostate Cancer Cells In Vitro
- (2013) Sandra Casimiro et al. PLoS One
- Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis
- (2013) Younghun Jung et al. Nature Communications
- Atypical Metastases From Prostate Cancer: 10-Year Experience at a Single Institution
- (2012) Anant H. Vinjamoori et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Angiogenesis in prostate cancer: onset, progression and imaging
- (2012) Giovanna Russo et al. BJU INTERNATIONAL
- CXCL1/GROα increases cell migration and invasion of prostate cancer by decreasing fibulin-1 expression through NF-κB/HDAC1 epigenetic regulation
- (2012) Po-Lin Kuo et al. CARCINOGENESIS
- Integrin alpha2beta1 (α2β1) promotes prostate cancer skeletal metastasis
- (2012) Joseph L. Sottnik et al. CLINICAL & EXPERIMENTAL METASTASIS
- Overcoming Drug Resistance and Treating Advanced Prostate Cancer
- (2012) Julius Semenas et al. CURRENT DRUG TARGETS
- A review on CXCR4/CXCL12 axis in oncology: No place to hide
- (2012) Urszula M. Domanska et al. EUROPEAN JOURNAL OF CANCER
- Systemic Delivery of Oncolytic Adenoviruses Targeting Transforming Growth Factor-β Inhibits Established Bone Metastasis in a Prostate Cancer Mouse Model
- (2012) Zebin Hu et al. HUMAN GENE THERAPY
- The Chemokine Superfamily Revisited
- (2012) Albert Zlotnik et al. IMMUNITY
- In vitro the behaviors of metastasis with suppression of VEGF in human bone metastatic LNCaP-derivative C4-2B prostate cancer cell line
- (2012) Lei Yang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Significance of IL-6 in the transition of hormone-resistant prostate cancer and the induction of myeloid-derived suppressor cells
- (2012) Chun-Te Wu et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Into the Eye of the Cytokine Storm
- (2012) J. R. Tisoncik et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Primary Xenografts of Human Prostate Tissue as a Model to Study Angiogenesis Induced by Reactive Stroma
- (2012) Viviana P. Montecinos et al. PLoS One
- CXCR4 Expression in Prostate Cancer Progenitor Cells
- (2012) Anna Dubrovska et al. PLoS One
- The additional value of TGFβ1 and IL-7 to predict the course of prostate cancer progression
- (2011) Caroline Schroten et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The IL-8-Regulated Chemokine Receptor CXCR7 Stimulates EGFR Signaling to Promote Prostate Cancer Growth
- (2011) R. K. Singh et al. CANCER RESEARCH
- Tumor Metastasis: Molecular Insights and Evolving Paradigms
- (2011) Scott Valastyan et al. CELL
- Regulation of VEGF, MMP-9 and metastasis by CXCR4 in a prostate cancer cell line
- (2011) Qinwen Wang et al. CELL BIOLOGY INTERNATIONAL
- Chemokine oligomerization and interactions with receptors and glycosaminoglycans: The role of structural dynamics in function
- (2011) C.L. Salanga et al. EXPERIMENTAL CELL RESEARCH
- Consistent interactions between tumor cell IL-6 and macrophage TNF-α enhance the growth of human prostate cancer cells in the bone of nude mouse
- (2011) Seung Wook Kim et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Steps in prostate cancer progression that lead to bone metastasis
- (2011) Jung-Kang Jin et al. INTERNATIONAL JOURNAL OF CANCER
- Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow
- (2011) Yusuke Shiozawa et al. JOURNAL OF CLINICAL INVESTIGATION
- Elevated levels of circulating IL-7 and IL-15 in patients with early stage prostate cancer
- (2011) Chantal Mengus et al. Journal of Translational Medicine
- Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers
- (2011) A. J. Armstrong et al. MOLECULAR CANCER RESEARCH
- SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
- (2011) Zhihu Ding et al. NATURE
- Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?
- (2011) Jones T. Nauseef et al. Nature Reviews Urology
- Blockade of transforming growth factor-beta (TGFβ) signaling inhibits osteoblastic tumorigenesis by a novel human prostate cancer cell line
- (2011) Sweta Mishra et al. PROSTATE
- Stromal cell-derived factor-1 and vascular endothelial growth factor as biomarkers for lymph node metastasis and poor cancer-specific survival in prostate cancer patients after radical prostatectomy
- (2011) Qinwen Wang et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Cytokines in Cancer Immunotherapy
- (2011) Sylvia Lee et al. Cancers
- Cytokine disbalance in common human cancers
- (2010) Zoran Culig BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Pathogenesis of osteoblastic bone metastases from prostate cancer
- (2010) Toni Ibrahim et al. CANCER
- CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression
- (2010) Xueqing Sun et al. CANCER AND METASTASIS REVIEWS
- Tumor cell-specific blockade of CXCR4/SDF-1 interactions in prostate cancer cells by hTERT promoter induced CXCR4 knockdown: A possible metastasis preventing and minimizing approach
- (2010) Yifei Xing et al. CANCER BIOLOGY & THERAPY
- New insights into the role of CXCR4 in prostate cancer metastasis
- (2010) Candece L. Gladson et al. CANCER BIOLOGY & THERAPY
- Reciprocal Activation of Prostate Cancer Cells and Cancer-Associated Fibroblasts Stimulates Epithelial-Mesenchymal Transition and Cancer Stemness
- (2010) E. Giannoni et al. CANCER RESEARCH
- Molecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis
- (2010) Federica Marchesi et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Interleukin-6 in bone metastasis and cancer progression
- (2010) Tasnim Ara et al. EUROPEAN JOURNAL OF CANCER
- VEGF and prostatic cancer: a systematic review
- (2010) Francisco Botelho et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Mechanism of lymph node metastasis in prostate cancer
- (2010) Kaustubh Datta et al. Future Oncology
- Molecular genetics of prostate cancer: new prospects for old challenges
- (2010) M. M. Shen et al. GENES & DEVELOPMENT
- Multiple Roles of Chemokine (C-C Motif) Ligand 2 in Promoting Prostate Cancer Growth
- (2010) J. Zhang et al. JNCI-Journal of the National Cancer Institute
- Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance
- (2010) Hiroshi Tanaka et al. NATURE MEDICINE
- VEGF Inhibitors and Prostate Cancer Therapy
- (2010) Jeanny Aragon-Ching et al. Current Molecular Pharmacology
- Dysfunctional Transforming Growth Factor- Receptor II Accelerates Prostate Tumorigenesis in the TRAMP Mouse Model
- (2009) H. Pu et al. CANCER RESEARCH
- A Destructive Cascade Mediated by CCL2 Facilitates Prostate Cancer Growth in Bone
- (2009) Xin Li et al. CANCER RESEARCH
- Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
- (2009) Qianben Wang et al. CELL
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- Emerging roles of chemokines in prostate cancer
- (2009) David Vindrieux et al. ENDOCRINE-RELATED CANCER
- Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cells
- (2009) Frédéric R Santer et al. ENDOCRINE-RELATED CANCER
- Targeting TGF-β in prostate cancer: therapeutic possibilities during tumor progression
- (2009) Elisabeth Jones et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Prostate cancer promotes CD11b positive cells to differentiate into osteoclasts
- (2009) Kosuke Mizutani et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Predominant Expression of CCL2 at the Tumor Site of Prostate Cancer Patients Directs a Selective Loss of Immunological Tolerance to CCL2 That Could Be Amplified in a Beneficial Manner
- (2009) L. Izhak et al. JOURNAL OF IMMUNOLOGY
- Differential Activation and Regulation of CXCR1 and CXCR2 by CXCL8 Monomer and Dimer
- (2009) M. W. Nasser et al. JOURNAL OF IMMUNOLOGY
- The Chemokine CXCL16 and Its Receptor, CXCR6, as Markers and Promoters of Inflammation-Associated Cancers
- (2009) Merav Darash-Yahana et al. PLoS One
- The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells
- (2009) Colm Morrissey et al. PROSTATE
- Effects of CXCR4 antagonist CTCE-9908 on prostate tumor growth
- (2009) Stacy Porvasnik et al. PROSTATE
- CX3CR1 Is Expressed by Prostate Epithelial Cells and Androgens Regulate the Levels of CX3CL1/Fractalkine in the Bone Marrow: Potential Role in Prostate Cancer Bone Tropism
- (2008) W. L. Jamieson et al. CANCER RESEARCH
- CXCR6 Induces Prostate Cancer Progression by the AKT/Mammalian Target of Rapamycin Signaling Pathway
- (2008) J. Wang et al. CANCER RESEARCH
- Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer
- (2008) Takuya Akashi et al. CANCER SCIENCE
- CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells
- (2008) Weidong Hu et al. CANCER SCIENCE
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Roles of TGFβ in metastasis
- (2008) David Padua et al. CELL RESEARCH
- Receptor activator of NF-κB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells
- (2008) Valerie A Odero-Marah et al. CELL RESEARCH
- Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone
- (2008) Yi Lu et al. CLINICAL & EXPERIMENTAL METASTASIS
- Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model
- (2008) Haiyen E. Zhau et al. CLINICAL & EXPERIMENTAL METASTASIS
- CXCL16 Functions as a Novel Chemotactic Factor for Prostate Cancer Cells In vitro
- (2008) Y. Lu et al. MOLECULAR CANCER RESEARCH
- RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis
- (2008) R. E. Miller et al. MOLECULAR CANCER THERAPEUTICS
- Expression of RANK‐ligand in prostate cancer cell lines
- (2008) Hendrik Penno et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now